Should I buy Kimberly-Clark (KMB) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (262 calls tested). It aims for $116 (+18 %), call made on August 6, 2026, maturing on August 6, 2027 (69 d ago).
Firm-by-firm track record on Kimberly-Clark
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B of A Securities | 67 % | +6.0 % | 6 | $120 +22% |
| JP Morgan | 74 % | +5.5 % | 19 | $129 +31% |
| Deutsche Bank | 60 % | +3.2 % | 5 | $109 +11% |
| Citigroup | 53 % | -2.3 % | 15 | $90 -8% |
| Piper Sandler | 29 % | -11.5 % | 7 | $118 +20% |
| RBC Capital | 14 % | -15.4 % | 7 | $162 +65% |
| Jefferies | 20 % | -5.6 % | 5 | — |
✅ Reasons to believe
- Median price target $116, i.e. +18% from the current price ($98).
- The most reliable firm on KMB, JP Morgan (74% hit rate, 19 scored calls), targets $129 (call made on October 31, 2025, maturing on October 31, 2026) (+31%) in its most recent call.
- Pays a dividend (4.6% yield), raised for 20 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~19) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 6 ratings, 4 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on KMB
Median target $116 (+18%) · 6 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Kimberly-Clark now?
We won't decide for you. The facts: 33% of analysts rate it a buy, median target $116 (+18%), and JP Morgan (most reliable on KMB, 74%) targets $129. Weigh that against valuation (P/E ~19). This is not personalized advice.
Is it too late to invest in Kimberly-Clark?
Not according to analysts: the median target ($116) is still +18% above the current price ($98) (most reliable on KMB: JP Morgan, 74%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Kimberly-Clark still worth investing in?
It depends on the gap between the price ($98) and its estimated value: analysts target $116 on median (+18%), with 33% buys (most reliable on KMB: JP Morgan, 74%). Cross-check with their real reliability on KMB and the cautions above. Information, not advice.
What's the main risk in buying KMB?
The consensus is not unanimous: of 6 ratings, 4 are neutral.
→ Go deeper: the full Kimberly-Clark profile (consensus, analyst reliability, price target, performance).